Fifty years of restricted research may be coming to an end. Reports that President Trump plans to direct cannabis rescheduling would finally open federally-funded clinical trials for cannabinoid therapeutics, and force the industry to answer questions it’s long avoided. Pharma companies like Jazz (Epidiolex) and AbbVie already have cannabinoid programs. This could accelerate M&A or…
The most innovative pharmaceutical agents of 2020
The Galien Foundation recently announced nominees for most innovative pharmaceutical agents for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical, pharmaceutical drugs and medical technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien…